Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical Implications.

Clinical genitourinary cancer·2026
Same author

External Validation of the International Bladder Cancer Group Intermediate-risk Non-muscle-invasive Bladder Cancer Substratification Model.

European urology oncology·2026
Same author

Epidemiological Trends and Germline Variant Analysis of Young-Onset Bladder Cancer.

Clinical genitourinary cancer·2026
Same author

Editorial Comment.

The Journal of urology·2026
Same author

Re-Evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches.

The Urologic clinics of North America·2026
Same author

Machine learning approaches to optimize the integration of sociodemographic factors for predicting cancer-specific survival among patients with high-risk prostate cancer.

Current urology·2026

相关实验视频

Updated: May 9, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

在局部前列腺癌中进行基于组织的基因表达测试.

Nethusan Sivanesan1, Gabriela M Diaz, Preston C Sprenkle

  • 1Yale School of Medicine, Department of Urology, New Haven, Connecticut, USA.

Current opinion in urology
|May 2, 2025
PubMed
概括
此摘要是机器生成的。

基于组织的基因组测试改善了前列腺癌 (PCa) 风险评估,超出了传统标记. 这些测试有助于治疗决策,减少低风险患者的过度治疗,并指导高风险个体的干预.

关键词:
基因表达的基因表达方式基因组分类器的基因组分类器前列腺癌是前列腺癌.风险分层的风险分层.

更多相关视频

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K
Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction
08:30

Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction

Published on: August 21, 2016

50.8K

相关实验视频

Last Updated: May 9, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K
Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction
08:30

Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction

Published on: August 21, 2016

50.8K

科学领域:

  • 在瘤学瘤学.
  • 基因组学就是基因组学.
  • 分子诊断学 分子诊断学

背景情况:

  • 局部化前列腺癌 (PCa) 管理受益于个性化风险分层.
  • 传统的标记 (PSA,格里森得分) 由于瘤异质性而存在局限性.
  • 基因组测试为PCa提供了增强的预后能力.

研究的目的:

  • 审查当前局部PCa的基于组织的基因组测试.
  • 探索基因组测试,临床应用,挑战和未来的方向.
  • 评估基因组测试在PCa风险分层和治疗决策中的作用.

主要方法:

  • 对本地化PCa.基因组测试的最新研究的文献综述.
  • 分析常用的基因组测试:解读,型DX (GPS) 和Prolaris.
  • 评估支持预后能力和治疗指导的临床证据.

主要成果:

  • 基因组测试提供了超越传统标记者的个性化风险分层.
  • 解密显示了确定的预后值;Prolaris和GPS需要进一步验证.
  • 基因组测试指导治疗选择,可能减少过度治疗和优化干预.

结论:

  • 基于组织的基因组测试正在成为PCa的有价值的预后工具.
  • 临床采用正在增长,但成本和获取等挑战仍然存在.
  • 需要进一步的前性研究来优化实施和验证长期影响.